Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sigma Healthcare Ltd ( (AU:SIG) ) has issued an announcement.
Sigma Healthcare Limited has received regulatory approvals from ASIC and ASX, enabling it to align its financial reporting with Chemist Warehouse following their merger. The approvals allow Sigma to report financial results based on a notional financial year ending on June 30, facilitating consistency between the two companies’ financial year ends. This change aims to simplify reporting obligations and enhance operational synergy post-merger, impacting stakeholders by providing a clearer financial overview.
More about Sigma Healthcare Ltd
Sigma Healthcare Limited operates in the healthcare industry, focusing on providing pharmaceutical products and services. It is primarily involved in the distribution of pharmaceutical goods and operates within the Australian market.
YTD Price Performance: 6.37%
Average Trading Volume: 7,634
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €19.12B
For an in-depth examination of SIG stock, go to TipRanks’ Stock Analysis page.
